Clinical Trial Results:
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes
Summary
|
|
EudraCT number |
2006-001767-31 |
Trial protocol |
GB |
Global completion date |
15 Apr 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Dec 2019
|
First version publication date |
02 Dec 2019
|
Other versions |
|
Summary report(s) |
The effect of interleukin-1 receptor antagonisttherapy on markers of inflammation in non-STelevationacutecoronarysyndromes:theMRC-ILAHeart Study |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.